Computer aided comparison of the new oral drug Molnupiravir and independently designed and previously reported drug like molecule (HAD-08) was written by Mullasseril, Abhilash. And the article was included in World Journal of Pharmaceutical Research in 2022.Formula: C13H19N3O7 The following contents are mentioned in the article:
The medicinal scientists and drug researchers around the world are facing various complicated challenges always but particularly in this pandemic period. They are constantly trying to overcome the hurdles of the puzzles given by the COVID-19. In this research work a computer aided comparison of the newly introduced oral drug Molnupiravir and an independently designed and previously reported drug like mol. (HAD-08) are compared without any prejudices. This study involved multiple reactions and reactants, such as ((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate (cas: 2492423-29-5Formula: C13H19N3O7).
((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate (cas: 2492423-29-5) belongs to tetrahydrofuran derivatives. Tetrahydrofurans and furans are important oxygen-containing heterocycles that often exhibit interesting properties for biological applications or applications in the cosmetic industry. Tetrahydrofuran (THF) is primarily used as a precursor to polymers including for surface coating, adhesives, and printing inks.Formula: C13H19N3O7
Referemce:
Tetrahydrofuran – Wikipedia,
Tetrahydrofuran | (CH2)3CH2O – PubChem